243 related articles for article (PubMed ID: 35181393)
1. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.
Yoshida S; Hasegawa T
Neurochem Int; 2022 May; 155():105307. PubMed ID: 35181393
[TBL] [Abstract][Full Text] [Related]
2. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
3. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
Victoria GS; Zurzolo C
J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
[TBL] [Abstract][Full Text] [Related]
4. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
5. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
6. The role of astrocytes in prion-like mechanisms of neurodegeneration.
Smethurst P; Franklin H; Clarke BE; Sidle K; Patani R
Brain; 2022 Mar; 145(1):17-26. PubMed ID: 35265969
[TBL] [Abstract][Full Text] [Related]
7. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
[TBL] [Abstract][Full Text] [Related]
8. Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases.
Natale G; Pompili E; Biagioni F; Paparelli S; Lenzi P; Fornai F
Eur J Histochem; 2013 Mar; 57(1):e5. PubMed ID: 23549464
[TBL] [Abstract][Full Text] [Related]
9. Propagation of the prion phenomenon: beyond the seeding principle.
Münch C; Bertolotti A
J Mol Biol; 2012 Aug; 421(4-5):491-8. PubMed ID: 22245492
[TBL] [Abstract][Full Text] [Related]
10. Defining the Protein Seeds of Neurodegeneration using Real-Time Quaking-Induced Conversion Assays.
Manca M; Kraus A
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32854212
[TBL] [Abstract][Full Text] [Related]
11. Trafficking and degradation pathways in pathogenic conversion of prions and prion-like proteins in neurodegenerative diseases.
Victoria GS; Zurzolo C
Virus Res; 2015 Sep; 207():146-54. PubMed ID: 25645281
[TBL] [Abstract][Full Text] [Related]
12. The propagation of prion-like protein inclusions in neurodegenerative diseases.
Goedert M; Clavaguera F; Tolnay M
Trends Neurosci; 2010 Jul; 33(7):317-25. PubMed ID: 20493564
[TBL] [Abstract][Full Text] [Related]
13. The seeds of neurodegeneration: prion-like spreading in ALS.
Polymenidou M; Cleveland DW
Cell; 2011 Oct; 147(3):498-508. PubMed ID: 22036560
[TBL] [Abstract][Full Text] [Related]
14. Prion-like transmission of protein aggregates in neurodegenerative diseases.
Brundin P; Melki R; Kopito R
Nat Rev Mol Cell Biol; 2010 Apr; 11(4):301-7. PubMed ID: 20308987
[TBL] [Abstract][Full Text] [Related]
15. Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases.
Arawaka S; Machiya Y; Kato T
Curr Pharm Biotechnol; 2010 Feb; 11(2):158-66. PubMed ID: 20170473
[TBL] [Abstract][Full Text] [Related]
16. The prion-like nature of amyotrophic lateral sclerosis.
McAlary L; Yerbury JJ; Cashman NR
Prog Mol Biol Transl Sci; 2020; 175():261-296. PubMed ID: 32958236
[TBL] [Abstract][Full Text] [Related]
17. Protein folding and aggregation: two sides of the same coin in the condensation of proteins revealed by pressure studies.
Silva JL; Cordeiro Y; Foguel D
Biochim Biophys Acta; 2006 Mar; 1764(3):443-51. PubMed ID: 16480935
[TBL] [Abstract][Full Text] [Related]
18. POSCAbilities: The Application of the Prion Organotypic Slice Culture Assay to Neurodegenerative Disease Research.
Pineau H; Sim V
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32698402
[TBL] [Abstract][Full Text] [Related]
19. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
20. Prion-like transmission of pathogenic protein aggregates in genetic models of neurodegenerative disease.
Pearce MM
Curr Opin Genet Dev; 2017 Jun; 44():149-155. PubMed ID: 28441621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
